X
Xeris Biopharma Holdings, Inc.
XERS · NASDAQ · Healthcare · 1.5B
Closing price
$10.48
+2.85% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
3034.8×
Price / net assetsP/B
122.8×
Enterprise value / EBITDAEV/EBITDA
126.5×
Free cash flow yieldFCF yield
1.7%
Return on equityROE
4.0%
Operating margin
8.5%
Net debt / EBITDAbalance-sheet strength
-5.8×
Interest coverage
0.9×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.